It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Longitudinal monitoring of liver function in vivo is hindered by the lack of high-resolution non-invasive imaging techniques. Using the anterior chamber of the mouse eye as a transplantation site, we have established a platform for longitudinal in vivo imaging of liver spheroids at cellular resolution. Transplanted liver spheroids engraft on the iris, become vascularized and innervated, retain hepatocyte-specific and liver-like features and can be studied by in vivo confocal microscopy. Employing fluorescent probes administered intravenously or spheroids formed from reporter mice, we showcase the potential use of this platform for monitoring hepatocyte cell cycle activity, bile secretion and lipoprotein uptake. Moreover, we show that hepatic lipid accumulation during diet-induced hepatosteatosis is mirrored in intraocular in vivo grafts. Here, we show a new technology which provides a crucial and unique tool to study liver physiology and disease progression in pre-clinical and basic research.
Longitudinal monitoring of liver function in vivo is hindered by the lack of high-resolution non-invasive imaging techniques. Here, the authors show a crucial and unique tool for longitudinal in vivo imaging of liver spheroids at cellular resolution to study liver physiology and disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Karolinska Institutet, The Rolf Luft Research Center for Diabetes and Endocrinology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
2 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
3 Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
4 Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); TU Dresden, Center for Regenerative Therapies Dresden, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257); University Medical Center Goettingen, Department of Pharmacology and Toxicology, Goettingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331)
5 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany (GRID:grid.502798.1) (ISNI:0000 0004 0561 903X); University of Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
6 Karolinska Institutet, The Rolf Luft Research Center for Diabetes and Endocrinology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Tecnológico de Monterrey, Monterrey, Mexico (GRID:grid.419886.a) (ISNI:0000 0001 2203 4701); University of Miami. Miller School of Medicine, Diabetes Research Institute, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)